JASON BLACK: Open Payments
NPI 1306013305 · LEBANON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$835 in 42 payments from 19 companies in 2025. Trend: 2023 $32 · 2024 $74 · 2025 $835
Food & beverage: $835
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $159 |
| GlaxoSmithKline, LLC. | 7 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $87 |
| Astellas Pharma US Inc | 3 | $67 |
| Lilly USA, LLC | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Novo Nordisk Inc | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
Products named: TRELEGY ELLIPTA, Kerendia, BREZTRI, Veozah, AIRSUPRA, CAPLYTA, KISUNLA, REXULTI.
Industry payments across TN — which companies pay providers there.
